Evidence map›Paper›PMID 21635964›Full record

ReviewProgress in retinal and eye research2011

Inflammation in diabetic retinopathy.

Johnny Tang, Timothy S Kern

Registry-linked trialAbstract readReview
In one paragraph

Review in Progress in retinal and eye research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05736081 (Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema), which is not on this map. Cited by 666 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
666citing papers in PubMed, 3 pooled it
35.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05736081 phase4completednot on this mapstarted 2018, after this paper: background citation

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

TypeinterventionalSponsorAsociación para Evitar la Ceguera en MéxicoRan2018 to 2019Enrolled15ConditionsDiabetic Macular EdemaArmsIntravitreal dexamethasone implant
3 · Its place in the literature

Who cites it

666 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,078 citations in OpenAlex.

  1. Association between diabetic retinopathy and age-related macular degeneration: a systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Bibliometric analysis and visualization of inflammation in the field of diabetic retinopathy research (2006-2025).Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Regulation of Glutathione Peroxidase 4 in Diabetic Retinopathy.International journal of molecular sciences · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A real-world study of Faricimab: efficacy and biomarkers in treatment-experienced neovascular age-related macular degeneration(nAMD) and diabetic macular edema (DME) patients.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  20. Article

606 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Johnny TangDepartment of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Case Western Reserve University, Cleveland, OH, USA.
Timothy S Kern
Louis Stokes Cleveland VA Medical Center · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
STUDY OF DIABETIC RETINOPATHYR01EY000300 · NEI · UNIVERSITY OF WISCONSIN MADISON · PI KERN, TIMOTHY S · 1985 to 2013
$4.7M
Study of diabetic retinopathyR56EY000300 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI KERN, TIMOTHY S · 2009 to 2009
$353k
NEI NIH HHS EY00300NEI NIH HHS R01 EY000300NEI NIH HHS R56 EY000300
6 · The paper itself

Abstract

Diabetes causes a number of metabolic and physiologic abnormalities in the retina, but which of these abnormalities contribute to recognized features of diabetic retinopathy (DR) is less clear. Many of the molecular and physiologic abnormalities that have been found to develop in the retina in diabetes are consistent with inflammation. Moreover, a number of anti-inflammatory therapies have been found to significantly inhibit development of different aspects of DR in animal models. Herein, we review the inflammatory mediators and their relationship to early and late DR, and discuss the potential of anti-inflammatory approaches to inhibit development of different stages of the retinopathy. We focus primarily on information derived from in vivo studies, supplementing with information from in vitro studies were important.

Indexed as

AnimalsCytokinesDiabetic RetinopathyDisease ProgressionHumansInflammationIntercellular Signaling Peptides and ProteinsNitric Oxide Synthase Type IIRetinal VesselsSignal TransductionTranscription FactorsCytokinesIntercellular Signaling Peptides and ProteinsNitric Oxide Synthase Type IITranscription Factors

Identifiers

PMID21635964
PMCPMC3433044
OpenAlexW2047640394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.